Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
No open-market purchases or sales by Faeth Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Faeth Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 30 | 45 | +15 |
| Shares | 2.16M | 14.1M | +11.9M (+552.6%) |
| Value | $68.0M | $333.8M | +$265.8M (+391.1%) |
New holders (22)
Institutions that held Faeth Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,444,039 | $36.1M | 0.32% |
| Baker Bros. Advisors LP | 1,286,411 | $32.2M | 0.16% |
| Ra Capital Management, L.P. | 722,020 | $18.1M | 0.16% |
| Fairmount Funds Management LLC | 722,020 | $18.1M | 1.19% |
| B Group, Inc. | 610,169 | $15.3M | 8.66% |
| Octagon Capital Advisors LP | 361,010 | $9.03M | 0.83% |
| ADAR1 Capital Management, LLC | 361,010 | $9.03M | 0.42% |
| Boxer Capital Management, LLC | 180,505 | $4.51M | 0.34% |
| Patient Square Capital LP | 175,050 | $4.38M | 0.68% |
| Alyeska Investment Group, L.P. | 144,404 | $3.61M | 0.01% |
| Affinity Asset Advisors, LLC | 144,404 | $3.61M | 0.18% |
| AWM Investment Company, Inc. | 111,343 | $2.78M | 0.24% |
| Richmond Investment Services, LLC | 79,731 | $1.99M | 0.63% |
| Superstring Capital Management LP | 14,175 | $354.4K | 0.22% |
| Barclays PLC | 12,412 | $310.3K | 0.00% |
| Citadel Advisors LLC | 12,296 | $307.4K | 0.00% |
| XTX Topco Ltd | 9,608 | $240.2K | 0.00% |
| China Universal Asset Management Co., Ltd. | 3,600 | $90.0K | 0.01% |
| BlackRock, Inc. | 3,402 | $85.0K | 0.00% |
| Royal Bank of Canada | 509 | $13.0K | 0.00% |
| Quarry LP | 32 | $800 | 0.00% |
| UMA Financial Services, Inc. | 28 | $700 | 0.00% |
Sold out (7)
Institutions that held Faeth Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Millennium Management LLC | 146,565 | $4.62M |
| StemPoint Capital LP | 132,873 | $4.19M |
| Goldman Sachs Group Inc | 61,568 | $1.94M |
| HRT Financial LP | 58,001 | $1.83M |
| Bank of America Corp | 33,025 | $1.04M |
| Brevan Howard Capital Management LP | 20,333 | $640.9K |
| Fred Alger Management, LLC | 18,337 | $578.0K |